Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

NCT03821610

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Heart of England Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Birmingham Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol Nhs Foundation Trust Bristol, United Kingdom
  • Cambridge University Hospitals Nhs Foundation Trust Cambridge, United Kingdom
View all 22 locations
View Trial Details
Active, Not Recruiting

Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas

NCT05400109

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)

NCT05429268

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Medical University Plovdiv Plovdiv, Bulgaria
  • Acibadem Cityclinica Mhat Tokuda Sofia, Bulgaria
  • Umhat Alexandrovska Sofia Sofia, Bulgaria
  • Umhat Sv. Ivan Rilski Ead Sofia, Bulgaria
View all 61 locations
View Trial Details
Active, Not Recruiting

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

NCT05637801

Conditions
Alzheimer Disease, Alzheimer Disease 1, Alzheimer Disease 10, +55 more
Locations
  • CCT Research - Gilbert Neurology Partners Gilbert, Arizona, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • CCT Research - Foothills Research Center Phoenix, Arizona, United States
  • Banner Sun Health Research Institute Sun City, Arizona, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT05618028

Conditions
B Cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +21 more
Locations
  • University of California Los Angeles Medical Center /ID# 246357 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 259081 New Haven, Connecticut, United States
  • Mount Sinai Medical Center-Miami Beach /ID# 248251 Miami Beach, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113 Fort Wayne, Indiana, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Cannabis Use Disorder Treatment Study

NCT04567394

Conditions
Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe, +10 more
Locations
  • Colorado State University Fort Collins, Colorado, United States
  • University of Tennessee Knoxvile Knoxville, Tennessee, United States
View Trial Details

Related conditions